Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.
What Advanced files
- Others52
- Investor Meet40
- Updates19
- Board Meeting11
- PPTs9
- Dividend/Bonus9
Advanced Enzyme Technologies Limited has informed the Exchange about Copy of Newspaper Publication
Advanced Enzyme Technologies Limited has extinguished 8,25,028 fully paid-up equity shares bought back through the open market route. This capital reduction lowers the total outstanding equity base, potentially enhancing shareholder value.
Advanced Enzyme received requests from five members of its founding group, who hold no shares, to be reclassified as public shareholders. This move, pending approvals, simplifies the shareholder structure, reflecting their current disassociation from the company.
Advanced Enzyme Technologies reported a Q1 FY27 revenue of INR 189.8 Cr (+2% YoY, -7% QoQ), noting a INR 10 Cr sales reversal impact. EBITDA came in at INR 51 Cr (-10% YoY) with 27% margins, and PAT at INR 38.6 Cr (-5% YoY). Management acknowledged a softer start due...
Advanced Enzyme Tech's board approved an open market buyback of shares worth up to ₹69.7 Cr, at a maximum price of ₹500 per share. This aims to acquire over 1.39 million shares, funded by internal resources. No new shares for 6 months post-buyback, reflecting capital management.